Elevated serum granulocyte-macrophage colony-stimulating factor levels during radiotherapy predict favorable outcomes in lung and esophageal cancer

The combination of exogenous granulocyte-macrophage colony-stimulating factor (GM-CSF) with radiotherapy (RT) has been demonstrated to strengthen the antitumor immune response. We hypothesized that the variation of GM-CSF during RT was correlated with cancer prognosis. We measured serum levels of GM...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Oncotarget
Main Authors: Deng, Guodong, Hu, Pingping, Zhang, Jingxin, Liu, Qiqi, Liang, Ning, Xie, Jian, Qiao, Lili, Luo, Hui, Xu, Deguo, Liu, Fengjun, Yu, Xinshuang, liu, Zhen, Lv, Yajuan, Zhang, Jiandong
פורמט: Artigo
שפה:Inglês
יצא לאור: Impact Journals LLC 2016
נושאים:
Research Paper
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5356724/
https://ncbi.nlm.nih.gov/pubmed/27835886
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13202
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים